Evidence map›Paper›PMID 19020086›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2008

Impaired bone development and increased mesenchymal progenitor cells in calvaria of RB1-/- mice.

Gabriel M Gutierrez, Elizabeth Kong, Yves Sabbagh, Nelson E Brown, Jong-Seo Lee, Marie B Demay, David M Thomas, Philip W Hinds

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 66 citations in OpenAlex.

  1. Review
  2. Macrophage Repolarization as a Therapeutic Strategy for Osteosarcoma.International journal of molecular sciences · 2023
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Gabriel M GutierrezMolecular Oncology Research Institute, Tufts Medical Center, Boston, MA 02111, USA.
Elizabeth Kong
Yves Sabbagh
Nelson E Brown
Jong-Seo Lee
Marie B Demay
David M Thomas
Philip W Hinds
Harvard University · USMolecular Oncology (United States) · USTufts Medical Center · USPeter MacCallum Cancer Centre · AU

Funding

Role of pRb in Osteogenesis, Cell Cycle Exit and CancerR01AG020208 · NIA · TUFTS MEDICAL CENTER · PI HINDS, PHILIP W. · 2002 to 2011
$3.6M
NIA NIH HHS AG020208NIA NIH HHS R01 AG020208
6 · The paper itself

Abstract

We have previously shown that the retinoblastoma protein (pRb) can activate expression of Runx2-dependent, bone-specific genes in cultured cells. We now show that pRb also plays a role early in osteogenesis, and that in primary RB1(-/-) calvarial cells there is an increased osteoprogenitor pool. To understand pRb's function in vivo, we generated a conditional RB1-KO mouse in which pRb expression is efficiently extinguished in osteoblasts. These animals display an apparent developmental defect in bones, most strikingly in the calvaria. Cultured RB1(-/-) calvarial osteoblasts fail to cease proliferation upon reaching confluence or following differentiation. Re-plating assays of primary RB1(-/-) calvarial cells after differentiation showed a clear adipogenic ability with increased multipotency. RB1(-/-) osteoblasts display a severe reduction in levels of mRNAs expressed late in differentiation. In this study, we present strong evidence that pRb has multiple regulatory roles in osteogenesis. Furthermore, in the absence of RB1(-/-) there is a larger pool of multipotent cells compared with the WT counterpart. This increased pool of osteoprogenitor cells may be susceptible to additional transforming events leading to osteosarcoma, and is therefore key to understanding RB1 as a target in malignancy.

Indexed as

Bone DevelopmentAnimalsCell ProliferationMesenchymal Stem CellsMiceMice, KnockoutOsteoblastsRetinoblastoma ProteinSkullRetinoblastoma Protein

Identifiers

PMID19020086
PMCPMC2585042
OpenAlexW2051729004

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.